Courtney L. Gaberino MD , Matthew C. Altman MD , Michelle A. Gill MD, PhD , Leonard B. Bacharier MD , Rebecca S. Gruchalla MD, PhD , George T. O’Connor MD , Rajesh Kumar MD , Gurjit K. Khurana Hershey MD, PhD , Meyer Kattan MD , Andrew H. Liu MD , Stephen J. Teach MD , Edward M. Zoratti MD , Patrice M. Becker MD , Alkis Togias MD , Cynthia Visness PhD , James E. Gern MD , William W. Busse MD , Daniel J. Jackson MD
{"title":"气道和全身干扰素反应失调促进城市儿童哮喘恶化。","authors":"Courtney L. Gaberino MD , Matthew C. Altman MD , Michelle A. Gill MD, PhD , Leonard B. Bacharier MD , Rebecca S. Gruchalla MD, PhD , George T. O’Connor MD , Rajesh Kumar MD , Gurjit K. Khurana Hershey MD, PhD , Meyer Kattan MD , Andrew H. Liu MD , Stephen J. Teach MD , Edward M. Zoratti MD , Patrice M. Becker MD , Alkis Togias MD , Cynthia Visness PhD , James E. Gern MD , William W. Busse MD , Daniel J. Jackson MD","doi":"10.1016/j.jaci.2024.12.1090","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Determining why some upper respiratory illnesses provoke asthma exacerbations remains an unmet need.</div></div><div><h3>Objective</h3><div>We sought to identify transcriptome-wide gene expression changes associated with colds that progress to exacerbation.</div></div><div><h3>Methods</h3><div>Two hundred eight urban children (6-17 years) with exacerbation-prone asthma were prospectively monitored for up to 2 cold illnesses. Exacerbation illnesses (Ex<sup>+</sup>), defined as colds leading to asthma exacerbations requiring systemic corticosteroids within 10 days, were compared to colds that resolved without exacerbation (Ex<sup>−</sup>). Peripheral blood and nasal lavage samples were collected at baseline and during colds for RNA sequencing. Interferon gene expression was compared between Ex<sup>+</sup> and Ex<sup>−</sup> illnesses. Generalized additive modeling revealed interferon response kinetics. Multiple linear regression models compared interferon expression to clinical variables.</div></div><div><h3>Results</h3><div>One hundred six participants were evaluated during 154 colds. There was greater upregulation of differentially expressed interferon genes during Ex<sup>+</sup> illnesses compared to Ex<sup>−</sup>. Ex<sup>+</sup> illnesses had greater average and steeper rise in interferon expression. Within 3 days of illness, interferon expression was positively associated with nasal rhinovirus quantity (nasal: adjusted <em>R</em><sup>2</sup> = 0.48, <em>P</em> = .015; blood: adjusted <em>R</em><sup>2</sup> = 0.22, <em>P</em> = .013), and interferon expression was negatively associated with percentage predicted forced expiratory volume in 1 second (nasal: β = −0.010, <em>P</em> = .048; blood: β = −0.008, <em>P</em> = .023). Participants with lower baseline interferon expression had shorter time to exacerbation, higher risk for exacerbation with viral illnesses, and greater increase in interferon expression during viral colds (nasal: β = −0.80, <em>P</em> < .0001; blood: β = −0.75, <em>P</em> < .0001).</div></div><div><h3>Conclusion</h3><div>Dysregulated interferon responses are important contributors to asthma exacerbation risk in children. Low baseline interferon expression followed by greater upregulation of interferon pathways in airway and blood during respiratory illnesses increased exacerbation risk. Targeting this pathway in at-risk individuals holds promise for the personalized prevention of asthma exacerbations.</div></div>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"155 5","pages":"Pages 1499-1509"},"PeriodicalIF":11.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dysregulation of airway and systemic interferon responses promotes asthma exacerbations in urban children\",\"authors\":\"Courtney L. Gaberino MD , Matthew C. Altman MD , Michelle A. Gill MD, PhD , Leonard B. Bacharier MD , Rebecca S. Gruchalla MD, PhD , George T. O’Connor MD , Rajesh Kumar MD , Gurjit K. Khurana Hershey MD, PhD , Meyer Kattan MD , Andrew H. Liu MD , Stephen J. Teach MD , Edward M. Zoratti MD , Patrice M. Becker MD , Alkis Togias MD , Cynthia Visness PhD , James E. Gern MD , William W. Busse MD , Daniel J. Jackson MD\",\"doi\":\"10.1016/j.jaci.2024.12.1090\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Determining why some upper respiratory illnesses provoke asthma exacerbations remains an unmet need.</div></div><div><h3>Objective</h3><div>We sought to identify transcriptome-wide gene expression changes associated with colds that progress to exacerbation.</div></div><div><h3>Methods</h3><div>Two hundred eight urban children (6-17 years) with exacerbation-prone asthma were prospectively monitored for up to 2 cold illnesses. Exacerbation illnesses (Ex<sup>+</sup>), defined as colds leading to asthma exacerbations requiring systemic corticosteroids within 10 days, were compared to colds that resolved without exacerbation (Ex<sup>−</sup>). Peripheral blood and nasal lavage samples were collected at baseline and during colds for RNA sequencing. Interferon gene expression was compared between Ex<sup>+</sup> and Ex<sup>−</sup> illnesses. Generalized additive modeling revealed interferon response kinetics. Multiple linear regression models compared interferon expression to clinical variables.</div></div><div><h3>Results</h3><div>One hundred six participants were evaluated during 154 colds. There was greater upregulation of differentially expressed interferon genes during Ex<sup>+</sup> illnesses compared to Ex<sup>−</sup>. Ex<sup>+</sup> illnesses had greater average and steeper rise in interferon expression. Within 3 days of illness, interferon expression was positively associated with nasal rhinovirus quantity (nasal: adjusted <em>R</em><sup>2</sup> = 0.48, <em>P</em> = .015; blood: adjusted <em>R</em><sup>2</sup> = 0.22, <em>P</em> = .013), and interferon expression was negatively associated with percentage predicted forced expiratory volume in 1 second (nasal: β = −0.010, <em>P</em> = .048; blood: β = −0.008, <em>P</em> = .023). Participants with lower baseline interferon expression had shorter time to exacerbation, higher risk for exacerbation with viral illnesses, and greater increase in interferon expression during viral colds (nasal: β = −0.80, <em>P</em> < .0001; blood: β = −0.75, <em>P</em> < .0001).</div></div><div><h3>Conclusion</h3><div>Dysregulated interferon responses are important contributors to asthma exacerbation risk in children. Low baseline interferon expression followed by greater upregulation of interferon pathways in airway and blood during respiratory illnesses increased exacerbation risk. Targeting this pathway in at-risk individuals holds promise for the personalized prevention of asthma exacerbations.</div></div>\",\"PeriodicalId\":14936,\"journal\":{\"name\":\"Journal of Allergy and Clinical Immunology\",\"volume\":\"155 5\",\"pages\":\"Pages 1499-1509\"},\"PeriodicalIF\":11.4000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Allergy and Clinical Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0091674925000089\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0091674925000089","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
Dysregulation of airway and systemic interferon responses promotes asthma exacerbations in urban children
Background
Determining why some upper respiratory illnesses provoke asthma exacerbations remains an unmet need.
Objective
We sought to identify transcriptome-wide gene expression changes associated with colds that progress to exacerbation.
Methods
Two hundred eight urban children (6-17 years) with exacerbation-prone asthma were prospectively monitored for up to 2 cold illnesses. Exacerbation illnesses (Ex+), defined as colds leading to asthma exacerbations requiring systemic corticosteroids within 10 days, were compared to colds that resolved without exacerbation (Ex−). Peripheral blood and nasal lavage samples were collected at baseline and during colds for RNA sequencing. Interferon gene expression was compared between Ex+ and Ex− illnesses. Generalized additive modeling revealed interferon response kinetics. Multiple linear regression models compared interferon expression to clinical variables.
Results
One hundred six participants were evaluated during 154 colds. There was greater upregulation of differentially expressed interferon genes during Ex+ illnesses compared to Ex−. Ex+ illnesses had greater average and steeper rise in interferon expression. Within 3 days of illness, interferon expression was positively associated with nasal rhinovirus quantity (nasal: adjusted R2 = 0.48, P = .015; blood: adjusted R2 = 0.22, P = .013), and interferon expression was negatively associated with percentage predicted forced expiratory volume in 1 second (nasal: β = −0.010, P = .048; blood: β = −0.008, P = .023). Participants with lower baseline interferon expression had shorter time to exacerbation, higher risk for exacerbation with viral illnesses, and greater increase in interferon expression during viral colds (nasal: β = −0.80, P < .0001; blood: β = −0.75, P < .0001).
Conclusion
Dysregulated interferon responses are important contributors to asthma exacerbation risk in children. Low baseline interferon expression followed by greater upregulation of interferon pathways in airway and blood during respiratory illnesses increased exacerbation risk. Targeting this pathway in at-risk individuals holds promise for the personalized prevention of asthma exacerbations.
期刊介绍:
The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.